|
POM121C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.49829999999984E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.74690000021016E-07 |
| Normal-vs-Stage2 |
1.524790E-01 |
| Normal-vs-Stage3 |
1.038210E-01 |
| Normal-vs-Stage4 |
3.092800E-01 |
| Stage1-vs-Stage2 |
6.163900E-02 |
| Stage1-vs-Stage3 |
1.486130E-02 |
| Stage1-vs-Stage4 |
9.023900E-03 |
| Stage2-vs-Stage3 |
9.903600E-01 |
| Stage2-vs-Stage4 |
7.065600E-01 |
| Stage3-vs-Stage4 |
6.867400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.65450000000034E-05 |
| Normal-vs-AfricanAmerican |
1.216040E-01 |
| Normal-vs-Asian |
7.395600E-02 |
| Caucasian-vs-AfricanAmerican |
5.060400E-01 |
| Caucasian-vs-Asian |
7.160400E-02 |
| AfricanAmerican-vs-Asian |
4.276500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.360250E-03 |
| Normal-vs-Female |
3.55170000000404E-05 |
| Male-vs-Female |
1.718220E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.598980E-01 |
| Normal-vs-Age(41-60Yrs) |
2.615300E-04 |
| Normal-vs-Age(61-80Yrs) |
4.576900E-04 |
| Normal-vs-Age(81-100Yrs) |
8.162400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.817600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.501400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.781400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.160600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.786350E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.095800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.467970E-02 |
| Normal-vs-Grade 2 |
4.9845999999798E-06 |
| Normal-vs-Grade 3 |
3.804400E-03 |
| Normal-vs-Grade 4 |
6.788600E-01 |
| Grade 1-vs-Grade 2 |
6.704300E-02 |
| Grade 1-vs-Grade 3 |
3.659700E-02 |
| Grade 1-vs-Grade 4 |
3.043200E-03 |
| Grade 2-vs-Grade 3 |
2.158400E-01 |
| Grade 2-vs-Grade 4 |
6.177800E-03 |
| Grade 3-vs-Grade 4 |
9.595900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.91440000413468E-08 |
| Normal-vs-ccB subtype |
7.119600E-03 |
| ccA subtype-vs-ccB subtype |
2.422200E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.030900E-04 |
| Normal-vs-N1 |
2.767000E-01 |
| N0-vs-N1 |
8.627600E-01 |
|
|
